Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Richer

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Clinical Pharmacology|June 24, 1999
Effect of sulfasalazine on cyclosporin blood concentrationD Du Cheyron, D Debruyne, T Lobbedez, et al.
Genes, Brain, and Behavior|February 18, 2009
Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic backgroundM M Cox, A M Tucker, J Tang, et al.
International Journal of Cancer|April 6, 2001
Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactionsM Krajinovic, P Ghadirian, C Richer, et al.
British Journal of Clinical Pharmacology|October 1, 1979
Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings]G Bianchetti, M Chauvin, J F Giudicelli, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in miceE Messadi-Laribi, V Griol-Charhbili, E Gaies, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 30, 2005
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemiaV Griol-Charhbili, E Messadi-Laribi, J L Bascands, et al.
Biochemical Pharmacology|January 28, 2015
Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouseG Youcef, E Belaidi, L Waeckel, et al.
Cardiovascular Research|August 6, 1999
Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failureI Espinasse, V Iourgenko, C Richer, et al.
Mbio|March 31, 2021
Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam AntimicrobialsKensuke Shima, Inga Kaufhold, Thomas Eder, et al.
Vascular Pharmacology|October 3, 2006
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problemsP Madeddu, C Emanueli, F Spillmann, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Pharmacology|June 24, 1999
Effect of sulfasalazine on cyclosporin blood concentrationD Du Cheyron, D Debruyne, T Lobbedez, et al.
Genes, Brain, and Behavior|February 18, 2009
Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic backgroundM M Cox, A M Tucker, J Tang, et al.
International Journal of Cancer|April 6, 2001
Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactionsM Krajinovic, P Ghadirian, C Richer, et al.
British Journal of Clinical Pharmacology|October 1, 1979
Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings]G Bianchetti, M Chauvin, J F Giudicelli, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in miceE Messadi-Laribi, V Griol-Charhbili, E Gaies, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 30, 2005
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemiaV Griol-Charhbili, E Messadi-Laribi, J L Bascands, et al.
Biochemical Pharmacology|January 28, 2015
Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouseG Youcef, E Belaidi, L Waeckel, et al.
Cardiovascular Research|August 6, 1999
Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failureI Espinasse, V Iourgenko, C Richer, et al.
Mbio|March 31, 2021
Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam AntimicrobialsKensuke Shima, Inga Kaufhold, Thomas Eder, et al.
Vascular Pharmacology|October 3, 2006
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problemsP Madeddu, C Emanueli, F Spillmann, et al.
Pageof 14